Biotech ETFs Are Not Riding the Wave from Coronavirus Panic
January 24, 2020 at 15:08 PM EST
Despite concerns of a spreading coronavirus out of China, biotechnology stocks and sector-related ETFs are not enjoying the usual bump on hopes of developing new treatments to counter the contagion. Among the worst performing non-leveraged ETFs of Friday, the Virtus LifeSci Biotech Clinical Trials...